EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fungal Metabolomics: A Comprehensive Approach to Understanding Pathogenesis in Humans and Identifying Potential Therapeutics

Vinicius Alves iD, Daniel Zamith-Miranda iD, Susana Frases iD, Joshua D Nosanchuk iD

Journal of Fungi · 24.01.2025 · 11 (2) · 93

DOI: 10.3390/jof11020093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Fungi, online erschienen am 24.01.2025. Verfasst von Vinicius Alves und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biofísica de Fungos, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Bra…. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Brazilian agencies National Council for Scientific and Technological Development (CNPq), the Coordination for the Improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolomics has emerged as a transformative tool in the study of microbes, including pathogenic fungi, facilitating the identification of unique metabolic profiles that elucidate their pathogenic mechanisms, host interactions, and treatment resistance. This review highlights key applications of metabolomics in understanding fungal metabolites essential for human virulence, such as mycotoxins produced by various fungal species, including Aspergillus fumigatus (gliotoxin, fumagillins) and Candida species (phenylethyl alcohol, TCA cycle metabolites), and secondary metabolites that contribute to pathogenicity. It also explores the metabolic adaptations of fungi in relation to drug resistance and biofilm formation, revealing alterations in key metabolic pathways during infection, as seen in C. albicans and C. auris. Furthermore, metabolomics aids in deciphering host–pathogen interactions, showcasing how fungi like Cryptococcus neoformans and Candida modify host metabolism to promote survival and evade immune responses. The study of antifungal resistance mechanisms has also benefited from metabolomic approaches, identifying specific metabolite patterns that signify resistance, such as in Candida albicans and Candidozyma (Candida) auris, and informing new therapeutic strategies. The integration of metabolomics with other omics technologies is paving the way for a comprehensive understanding of fungal biology and pathogenesis. Such multi-omics approaches are crucial for discovering new therapeutic targets and developing innovative antifungal treatments. Thus, the purpose of this review is to provide an overview of how metabolomics is revolutionizing our understanding of fungal pathogenesis, drug resistance, and host interactions, and to highlight its potential for identifying new therapeutic targets and improving antifungal strategies.

Schlagwörter

Stichwörter der Autor:innen

fungal infectionmetabolomicssecondary metabolism

Autor:innen und Institutionen

  • Laboratório de Biofísica de Fungos, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Rede Micologia RJ, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro-FAPERJ, Rio de Janeiro 21040-360, Brazil.
  • Department of Medicine (Infectious Diseases), Albert Einstein College of Medicine, Bronx, NY 10461, USA.

ORCID-Profile: Vinicius Alves, Daniel Zamith-Miranda, Susana Frases, Joshua D Nosanchuk

Förderung

  • NIAID NIH HHS
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Brazilian agencies National Council for Scientific and Technological Development (CNPq), the Coordination for the Improvement of Higher Education Personnel
  • National Institutes of Health (NIH)
  • Einstein 2030 Seed Fund

Zitieren

APA

Alves, V., Zamith-Miranda, D., Frases, S., & Nosanchuk, J. D. (2025). Fungal Metabolomics: A Comprehensive Approach to Understanding Pathogenesis in Humans and Identifying Potential Therapeutics. Journal of Fungi, 11(2), 93. https://doi.org/10.3390/jof11020093

Vancouver

Alves V, Zamith-Miranda D, Frases S, Nosanchuk JD. Fungal Metabolomics: A Comprehensive Approach to Understanding Pathogenesis in Humans and Identifying Potential Therapeutics. Journal of Fungi. 2025;11(2):93. doi:10.3390/jof11020093

BibTeX
@article{Alves2025,
  author = {Alves, Vinicius and Zamith-Miranda, Daniel and Frases, Susana and Nosanchuk, Joshua D},
  title = {Fungal Metabolomics: A Comprehensive Approach to Understanding Pathogenesis in Humans and Identifying Potential Therapeutics},
  journal = {Journal of Fungi},
  year = {2025},
  volume = {11},
  number = {2},
  pages = {93},
  doi = {10.3390/jof11020093}
}
Kostenlos starten →